Get In Touch

Cellulitis is one of the common skin infections caused by bacteria; mostly streptococcus sp. and staphylococcus sp. According to a study published by the AMA Journal of Ethics, cellulitis is defined as an acute inflammatory disorder which takes place in dermis and subcutaneous layer of the tissue. It can occur in any part of the body; however, lower legs and surrounding areas of wrist and fingers (face and neck in children) are mostly infected by streptococcus sp. and staphylococcus sp. Common symptoms of cellulitis include swelling, skin redness, fever, red spots, and skin dimpling.

Cellulitis can begin with any break of the skin, for example, minor scratch or insect bites which permits bacteria to enter the deeper layers of the skin. Health care practitioners indicate that cellulitis is high among healthy adults. It mostly occurs in children and adults who have weakened immune system.

Proper usage of antibacterial drugs are adequate to treat cellulitis. The global cellulitis treatment market is primarily driven by increase in cases of cellulitis across the world, rise in diagnosis & treatment rate of cellulitis, and improving health care infrastructure. However, stringent regulatory guidelines and less public awareness are projected to hamper the growth of the global cellulitis treatment market during the forecast period. Ongoing clinical trials on antibacterial drugs, increase in R&D investment by major players, and mergers & acquisitions among the key players are anticipated to propel the global market from 2018 to 2026.

In terms of drug class, the global cellulitis treatment market can be segmented into glycopeptide, fluoroquinolone, dehydropeptidase inhibitors, macrolide, cephalosporin, and others. Based on route of administration, the global market can be classified into enteral, parenteral, and others. In terms of drug type, the global cellulitis treatment market can be bifurcated into branded and generic. Based on distribution channel, the global market can be categorized into hospital pharmacies, retail pharmacies & drug stores, and others.

Geographically, the global cellulitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. A study conducted by the University of Utah School of Medicines, the U.S. concluded that incidence of cellulitis was around 25 per 1,000 persons-year in 2017. Higher incidence of cellulitis was documented among men aged 45 to 65 years. The same study also indicated that lower extremity parts of the body were mostly infected, followed by upper extremity such as head/face/neck and trunk. North America held the largest share of the global market in 2017 owing to significant incidence of cellulitis among the population, high awareness about cellulitis, and high diagnosis and treatment rate of cellulitis.

Germany, France, and the U.K. held major shares of the cellulitis treatment market in Europe in 2017. The market in Italy and Spain is projected to experience significant growth during the forecast period. Highly developed health care industry, established research and development infrastructure, availability of drugs, presence of major players, and contribution of small companies are the key factors attributed to Germany, France, and the U.K.’s leading shares of the market in Europe in 2017. Developing health care infrastructure is likely to propel the cellulitis treatment market in Italy and Spain in the next few years.

China and Japan held the dominant shares of the cellulitis treatment market in Asia Pacific in 2017. The market in India is expected to expand at a high CAGR in the near future, owing to the emerging health care industry and presence of well-established domestic players. Underdeveloped health care industry and lack of awareness about cellulitis are likely to hamper the growth of the market in Latin America and Middle East & Africa during the forecast period.

Key companies in the global cellulitis treatment market are Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG, Shionogi & Co., Ltd., and Pfizer, among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Cellulitis Treatment Market

Pre Book